3:10 pm
Mon May 21, 2012

The Director of the Hereditary Cancer Center at Creighton weighs in on Task Force recommendation

A Creighton University oncologist is critical of an announcement by the United States Preventive Services Task Force about PSA-based screenings.

The Task Force announced this afternoon its recommendation against prostate-specific antigen or PSA-based screenings for all men regardless of age. Dr. Henry Lynch is the Director of the Hereditary Cancer Center at Creighton. 

Read more
1:26 pm
Wed April 25, 2012

Alegent Health to acquire Creighton University Medical Center, expand teaching affiliations


Alegent Health expects its two new agreements with Creighton University to become official July first.

Read more
8:09 am
Tue April 24, 2012

April is Get Yourself Tested Month

Dr. Adi Pour, Director of the Douglas County Health Department, says they’ve known since 2004 that the rate of STD infections in Douglas County is at an epidemic level.

She says the health department wants to take every opportunity to keep young people healthy.  Dr. Pour says one of the ways to do so is to increase screening rates. 

She says often these types of infections are asymptomatic, so people may not know they are infected.

Read more
11:58 am
Thu March 22, 2012

Lynch Syndrome Awareness Day in Nebraska

An estimated three of every 100 cases of colon cancer are the result of a hereditary genetic condition called Lynch Syndrome.

Thursday is Lynch Syndrome Awareness Day. It’s named for Dr. Henry Lynch, the Director of Creighton University’s Hereditary Cancer Center. He discovered the genetic condition, which is passed down through generations. People with Lynch Syndrome are at increased risk of colon and other types of cancer.

Read more
1:47 pm
Mon February 20, 2012

UNMC breast cancer researcher pushes science forward with his research

Researchers at UNMC are making strides in dealing with Her2. 

Dr. Kay Wagner says Her2 is an aggressive type of breast cancer.  He says there are several subsets and that each case must be treated differently. 

Dr. Wagner says in previous studies, it was thought that by inhibiting a certain protein called Cyclin D1, the growth of breast cancer cells could be stopped or slowed.  But he says his research indicated the opposite was true.

Read more